优化皮拉津胺的使用:改善结核性脑膜炎的结果的低挂水果? 叙事审查 叙事审查
Bella Devaleenal Daniel1, Leeberk Raja Inbaraj2, Shanmugapriya Kumaravadivelu2
1ICMR, National Institute for Research in Tuberculosis, No. 1, Mayor Sathyamoorthy Road, Chennai, Tamil Nadu, India. belladevaleenal@gmail.com.
Infectious diseases and therapy
|January 3, 2025
概括
皮拉津胺可以改善治疗结果,减少结核性脑膜炎 (TBM) 的残疾,因为它可以在整个治疗过程中使用,而不仅仅是密集期. 这种方法需要对TBM患者进行进一步的研究.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核性脑膜炎 (TBM) 在超过三分之一的患者中造成显著残疾.
- 目前的研究优先考虑了利法西因剂量优化用于TBM治疗.
- 皮拉津胺对于中枢神经系统的透至关重要,在TBM治疗中经常被不足利用.
研究的目的:
- 评估延长在结核性脑膜炎治疗期间使用pyrazinamide的潜在临床影响.
- 为了将这种延长的使用与目前仅在密集阶段使用它的标准进行对比.
主要方法:
- 对体外研究,临床队列和与TBM中pyrazinamide相关的毒性数据的审查.
- 对基线耐药性比率对pyrazinamide的分析.
- 讨论正在进行的研究这种治疗方法的临床试验.
主要成果:
- 与其他抗结核药物相比,Pyrazinamide显示出更高的中枢神经系统透率.
- 来自现有研究的数据表明,在TBM中使用延长型皮拉津胺有潜在的益处.
- 在评估中正在考虑毒性概况和耐药率.
结论:
- 在抗结核治疗期间延长皮拉津胺的使用可能会提高TBM治疗的疗效.
- 这一战略有望减少与结核性脑膜炎相关的长期残疾.
- 目前正在进行的临床试验将提供关于皮拉津胺在TBM中最佳使用的进一步证据.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298


